FOR THE BIGGER IN VITRO (IVD) COMPANIES, the third quarter (Q3) ending Sept. 30 was a time when diagnostic sales rose—molecular testing is skyrocketing, actually—while other corporate divisions continued to lag amid the COVID-19 pandemic. Here are recaps of Q3 earnings reports and investor calls from leading companies serving clinical laboratories with instrument platforms, diagnostic […]
- IVD Update
IVD Firms Report Robust Growth In Third Quarter Financial Reports
Demand for COVID-19 molecular tests exceeds ability of companies to manufacture enough tests
- By Robert Michel
- > From the Volume XXVII, No. 16 - November 16, 2020 Issue
- Tags: COVID-19 Antigen Testing, COVID-19 Molecular Testing, COVID-19 molecular tests, COVID-19 Rapid Testing, COVID-19 serology tests, COVID-19 test, COVID-19 test kits, covid-19 testing, COVID-19 tests, in vitro diagnostics, in vitro diagnostics companies, in vitro diagnostics industry, in vitro diagnostics market, ivd/lab informatics
